These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 1611969)
1. [Androgens and bone metabolism. Significance in osteoporosis in man and woman]. Kasperk CH; Ziegler R Dtsch Med Wochenschr; 1992 Jun; 117(25):990-6. PubMed ID: 1611969 [No Abstract] [Full Text] [Related]
2. Treatment of postmenopausal osteoporosis with gonadal steroids. Henneman PH Semin Drug Treat; 1972; 2(1):15-9. PubMed ID: 5065515 [No Abstract] [Full Text] [Related]
4. [Etiology and risk factors of involutional osteoporosis]. Orimo H; Kaneki M Nihon Rinsho; 1990 Dec; 48(12):2862-6. PubMed ID: 2086846 [No Abstract] [Full Text] [Related]
5. [Significance of vitamin D and its metabolites in the pathogenesis and therapy of osteoporosis]. Scharla SH; Ziegler R Dtsch Med Wochenschr; 1994 Jun; 119(23):847-51. PubMed ID: 8005057 [No Abstract] [Full Text] [Related]
6. Anabolic steroids in postmenopausal osteoporosis. Need AG; Durbridge TC; Nordin BE Wien Med Wochenschr; 1993; 143(14-15):392-5. PubMed ID: 8256455 [TBL] [Abstract][Full Text] [Related]
8. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling]. Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165 [TBL] [Abstract][Full Text] [Related]
9. [What to use to treat osteoporosis?]. Välimäki MJ Duodecim; 2003; 119(24):2409-12. PubMed ID: 14870501 [No Abstract] [Full Text] [Related]
10. Metabolic changes in bone in old age. Pratelli L; Ravaglia G; Ciapetti G; Pizzoferrato A Ital J Orthop Traumatol; 1992; 18(1):95-105. PubMed ID: 1399540 [TBL] [Abstract][Full Text] [Related]
11. [Clinical aspects of bone mineral content in osteoporosis]. Nishizawa Y; Miki T; Nakatsuka K; Hagiwara S; Iba K; Morii H Nihon Ronen Igakkai Zasshi; 1992 Apr; 29(4):257-61. PubMed ID: 1614003 [No Abstract] [Full Text] [Related]
13. Prevention and treatment of postmenopausal and "senile" osteoporosis. Med Lett Drugs Ther; 1969 Dec; 11(25):101-3. PubMed ID: 5375105 [No Abstract] [Full Text] [Related]
15. [Bone and Men's Health. Androgen replacement therapy and bone metabolism]. Ogawa S Clin Calcium; 2010 Feb; 20(2):251-7. PubMed ID: 20118518 [TBL] [Abstract][Full Text] [Related]
16. [Biochemical markers of bone turnover. New aspect. Effects of androgen and estrogen on biochemical markers of bone turnover]. Ohnaka K; Takayanagi R Clin Calcium; 2009 Aug; 19(8):1118-24. PubMed ID: 19638695 [TBL] [Abstract][Full Text] [Related]
17. Bone anabolic agents: the unanswered queries. Adami S; Viapiana O; Gatti D Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):257-9. PubMed ID: 15228496 [No Abstract] [Full Text] [Related]
18. [Osteoporosis--diagnosis and therapy]. Ziegler R Med Klin (Munich); 1996 Feb; 91 Suppl 1():29-33. PubMed ID: 8839111 [No Abstract] [Full Text] [Related]
19. [Age-dependent decrease in plasma androgens, and role of androgens in bone mineral density and bone metabolism]. Adachi M; Takayanagi R Clin Calcium; 2006 Mar; 16(3):419-27. PubMed ID: 16508123 [TBL] [Abstract][Full Text] [Related]
20. [Postmenopause osteoporose as a period of normal bone transformation (author's transl)]. Krokowski E Med Klin; 1974 Dec; 69(51-52):2100-5. PubMed ID: 4444673 [No Abstract] [Full Text] [Related] [Next] [New Search]